Home > News > FUSE Binding Protein 1

19.10.2015: Veranstaltung des LOEWE-CGT:

– Academia meets Industry –Neue Ansätze in der Zell- und Gentherapie

The event of the LOEWE-CGT, under the auspices of the Goethe-University of Frankfurt (President Prof. Bettina Wolff), has delivered insights into the topical results of research in the field of cell- and gene therapy from scientific and industrial view.

In two Sessions members of industry, for example Kiadis Pharma, Merck Millipore, Miltenyi & Novartis as well as scientists of the LOEWE-CGTs report in exciting talks on the most topical developments in cell- and gene therapy.

  • When:
    Monday, 19. Oktober 2015, 16:00 - 19:00

  • Where:
    Georg-Speyer-House, lecture hall
    Paul-Ehrlich-Str.
    42-44
    60596 Frankfurt am Main

Welcome of Prof. Andreas Zeiher, member of the board of directors of LOEWE-CGT.

Prof. Birgit Aßmus (right hand) with her exciting talk about “Cell therapy in cardiovascular disease”. Chair of the first Session: Frau Prof. Stefanie Dimmeler (left hand).

Dr. Georg Rauser, Medical Science Manager of Miltenyi Biotec GmbH, speaks about “Automated manufacturing of genetically modified T cells for therapy”.

Prof. Dr. Peter Bader, Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents Frankfurt and member of the Executive Board of LOEWE-CGT refers about „Cellular immunotherapy after allogeneic stem cell transplantation“

Dr. Manfred Rüdiger, Chief Executive Officer of Kiadis Pharma provides an insight into “ATIR for haploidentical stem cell transplantation without the risk of grade III/IV GvHD”.

The auditory of the Georg-Speyer-House.

Downloads

Agenda
(PDF, 376,91kB)
schma
(PDF, 358,01kB)
Logo: Paul-Ehrlich-Institut Logo: Georg Speyer Haus Logo: Goethe Universität Logo: Max-Planck-Institut Logo: DRK Blutspendedienst